Skip to main content

Advertisement

Fig. 1 | BMC Cancer

Fig. 1

From: Demethylation of HIN-1 reverses paclitaxel-resistance of ovarian clear cell carcinoma through the AKT-mTOR signaling pathway

Fig. 1

a Morphologic changes of ES2 and ES2TR160 cells before and after paclitaxel treatment. Note: There were more floating ES2 cells than floating ES2TR160 cells. b Cell growth curves of ES2 and ES2TR160 cells treated with or without 160 nM paclitaxel by MTT assays. c The percentages of sub-G1, G1 and G2 phases among parental ES2 and ES2TR160 cells analyzed by flow cytometry. d The percentages of sub-G1, G1 and G2 phases among parental ES2 and ES2TR160 cells treated with different concentrations of paclitaxel analyzed by flow cytometry

Back to article page